(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LYMPHOPREP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LYMPHOPREP

ST13

US500000073088963

Class

1

Filing

73088963

Registration

1058103

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

02/09/2026

Trademark type

Word

Nice classes

1

Filing date

06/01/1976

Registration date

02/08/1977

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/02/2016

Last transaction

02/09/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

02/10/1972

First use in commerce

09/05/1972

Drawing code

1

Owner type

25

Owner location

BERNBURG, DE

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

SERUMWERK BERNBURG AG
A. A. (pessoa física)
A. A. (pessoa física)
N. A. (pessoa física)
NYEGAARD & CO. A.S.

Representatives

Anamaria E. Cashman Abbott Laboratories

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

CHEMICAL FOR USE IN LYMPHOCYTE SEPARATION

Publications

History of USPTO decisions and trademark events.

25 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/08/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/09/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/11/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/01/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/11/2016

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

05/02/2016

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

05/02/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/02/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/02/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

02/24/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/24/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/24/2014

CFIT

CASE FILE IN TICRS

11/06/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/23/2007

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/23/2007

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

05/23/2007

PLGL

ASSIGNED TO PARALEGAL

04/05/2007

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/14/2007

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

03/08/2007

E89R

TEAS SECTION 8 & 9 RECEIVED

03/08/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/08/1997

PRA9

POST REGISTRATION ACTION MAILED - SEC. 9

03/26/1997

9.AF

REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8

02/07/1996

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/27/1983

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

06/07/1977

Continuous trademark protection

Get notified about every new filing that threatens LYMPHOPREP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.